146. Deputy Eamon Scanlon asked the Minister for Health the reason the drug kuvan for the treatment of phenylketonuria is not available for reimbursement here in view of the fact that it is widely available worldwide; if consideration has been given to fund kuvan, weighing up the significant beneficial outcome in long-term health improvements; and if he will make a statement on the matter. [43162/17]

Summary

146. Deputy Eamon Scanlon asked the Minister for Health the reason the drug kuvan for the treatment of phenylketonuria is not available for reimbursement here in view of the fact that it is widely available worldwide; if consideration has been given to fund kuvan, weighing up the significant beneficial outcome in long-term health improvements; and if he will make a statement on the matter. [43162/17]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Reimbursement

  xml · EN · 11 October 2017

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.